(RAD) Rite Aid Corporation – Bear of the Day
Management at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the profitability of the existing store base. However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.
Moreover, Wal-Mart’s foray into the retail generic drug market has pressured the company’s pharmacy margin.
Given the weakness of front-end sales and management’s continual lowering of EPS guidance (for larger net losses), the stock’s rating remains Underperform.
Zacks Investment Research
View original at: Zacks.com News Feed
Similar Posts: RAD | Rite Aid Corporation | Drug Stores | Services
RSS feeds:
RAD | Rite Aid Corporation | Drug Stores | Services |
Other Posts by vitalstocks | RSS Feed for this author